FDA Inspection 1254190 — iCE Neurosystems, Inc.

iCE Neurosystems, Inc. — FEI 3018078670

The FDA completed an inspection of iCE Neurosystems, Inc. on Nov 6, 2024 in Washington, DC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 6, 2024
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Washington, DC (United States)

Citations

IDCFRDescription
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
311721 CFR 820.70(i)Software validation for automated processes
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.